Clinical Cancer Research | American Association for Cancer Research

Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
Cancer Hallmarks
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
Cancer Hallmarks
Webinars

Skip Nav Destination

Current Issue

Volume 29,

Issue 18

15 September 2023

View This Issue

About the Journal

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; immunotherapy; gene therapy; diagnostic biomarkers; innovative imaging, and clinical genetics. Read More About the Journal

Editor-in-Chief

Keith T. Flaherty

View Full Editorial Board

Impact Factor

11.5

SUBMIT TO JOURNAL

Featured Articles

Clinical Trials: Targeted Therapy

CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

Anfal Alsadhan, et al.

CCR Translations

Mutual ATRaction: Assessing Synergy of Berzosertib with Sacituzumab Govitecan

Stephanie A. Berg; Atish D. Choudhury

Clinical Trials: Targeted Therapy

Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer

Steven B. Maron, et al.

Trending - Altmetric

The article titled, Entinostat enhances the efficacy of chemotherapy in small cell lung cancer through S-phase arrest and decreased base excision repair, has an Alt Metric Attention Score of 38.08. Click to see more of this article's metrics.

Read the article titled, Entinostat enhances the efficacy of chemotherapy in small cell lung cancer through S-phase arrest and decreased base excision repair

Last mentioned on Thursday September 21 2023

The article titled, Driving Diversity and Inclusion in Cancer Drug Development – Industry and Regulatory Perspectives, Current Practices, Opportunities, and Challenges, has an Alt Metric Attention Score of 49.95. Click to see more of this article's metrics.

Read the article titled, Driving Diversity and Inclusion in Cancer Drug Development – Industry and Regulatory Perspectives, Current Practices, Opportunities, and Challenges

Last mentioned on Wednesday September 20 2023

The article titled, Advanced age in humans and mouse models of glioblastoma show decreased survival from extratumoral influence, has an Alt Metric Attention Score of 7.4. Click to see more of this article's metrics.

Read the article titled, Advanced age in humans and mouse models of glioblastoma show decreased survival from extratumoral influence

Last mentioned on Thursday September 21 2023

The article titled, Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-associated Immunity in Lynch Syndrome, has an Alt Metric Attention Score of 81.28. Click to see more of this article's metrics.

Read the article titled, Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-associated Immunity in Lynch Syndrome

Last mentioned on Thursday September 21 2023

The article titled, Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics, has an Alt Metric Attention Score of 66.2. Click to see more of this article's metrics.

Read the article titled, Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics

Last mentioned on Thursday September 21 2023

Latest
Most Read
Most Cited

PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors

Differential benefit of metronomic chemotherapy among triple negative breast cancer subtypes treated in the IBCSG Trial 22-00

Near-infrared spectral tomography for predicting residual cancer burden during early stage neoadjuvant chemotherapy for breast cancer

PD-1 blockade induces reactivation of non-productive T cell responses characterized by NF-kB signaling in patients with pancreatic cancer

The Twitter live feed is not currently active.

Keep up to date with Clinical Cancer Research

Follow @CCR_AACR

Issues
Online First
Collections

News
Twitter

Online ISSN 1557-3265
Print ISSN 1078-0432

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Information for Institutions/Librarians
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2023 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept